APTAMIR THERAPEUTICS
AptamiR Therapeutics is a biotechnology company that focuses on developing a revolutionary treatment for human obesity. Based on an innovative strategy targeting subcutaneous fat cells rather than the central nervous system or the intestinal absorption of food, AptamiR is developing microRNA-targeted therapeutics that enhance thermogenesis, turning fat-storing white adipocytes into fat-burning adipocytes (brown-like, brite or beige). MicroRNAs are attractive drug candidates for complex diseases ... like obesity, as they can modulate the expression of gene networks. AptamiR is also developing drug delivery approaches that can specifically target microRNA modulators to adipose tissue. It provides treatment for human obesity by targeting peripheral white and brown adipose tissues and is based on an innovative strategy targeting subcutaneous fat cells rather than the central nervous system or the intestinal absorption of food that enables patients to get the excess fat removed from their body. AptamiR Therapeutics was established in 2012 and is headquartered in Austin, Texas.
APTAMIR THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2012-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.aptamir.com
Total Employee:
1+
Status:
Active
Contact:
12128368433
Total Funding:
3 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API WordPress Google Analytics LetsEncrypt Google Universal Analytics Sitelinks Search Box Yoast WordPress SEO Plugin Nginx
Similar Organizations
Atelier Meats
Atelier Meats is a biotechnology company dedicated to developing quality meats competitively priced for human consumption.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.aptamir.com
- Host name: 196.109.196.104.bc.googleusercontent.com
- IP address: 104.196.109.196
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "AptamiR Therapeutics"
Our Company - AptamiR
AptamiR is developing breakthrough therapies based on the research of Craig Mello and Andrew Fire who won the 2006 Nobel Prize for Physiology or Medicine for the discovery of RNA …See details»
AptamiR Therapeutics - Crunchbase Company Profile & Funding
AptamiR Therapeutics is a biotechnology company that focuses on developing a revolutionary treatment for human obesity. Based on an innovative strategy targeting subcutaneous fat cells …See details»
AptamiR Therapeutics, Inc. - Company Profile & Staff Directory
AptamiR’s goal is to develop new therapies that target fat accumulation, inflammation, and necrosis to cure related cardiometabolic disorders (obesity, dyslipidemia, diabetes and …See details»
AptamiR Therapeutics, Inc. - $1.3 M Revenue - Kona Equity
AptamiR Therapeutics, Inc. (aptamir.com) in Austin, TX. AptamiR Therapeutics is a modular biotechnology company that specializes in virtual drug discovery to treat obesity. They develop …See details»
APTAMIR THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for APTAMIR THERAPEUTICS, INC. of Naples, FL. Get the latest business insights from Dun & Bradstreet.See details»
AptamiR Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore AptamiR Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 literature, Disease Domain:Endocrinology and Metabolic Disease, Technology …See details»
AptamiR Therapeutics Company Profile 2024: Valuation, Funding ...
AptamiR Therapeutics was founded in 2012. Where is AptamiR Therapeutics headquartered? AptamiR Therapeutics is headquartered in Naples, FL. What industry is AptamiR Therapeutics …See details»
AptamiR Therapeutics - Contacts, Employees, Board Members
Organization. AptamiR Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. AptamiR Therapeutics has 1 current employee profile, …See details»
Marc Thibonnier, M.D., M.Sc. - AptamiR
Dr. Thibonnier is the Founder and President of AptamiR Therapeutics, Inc. As a Physician-Scientist, he led a successful career in academic medicine in France and the USA up to the …See details»
AptamiR Therapeutics - Craft
AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders. It provides microRNA-targeted therapeutics that …See details»
APTAMIR EUROPE - Crunchbase Company Profile & Funding
Organization. APTAMIR EUROPE . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... APTAMIR EUROPE is funded by Eurasante. When was the …See details»
Aptamir Therapeutics - VentureRadar
AptamiR Therapeutics has created an innovative model of virtual and outsourced Drug Research & Development to cure human obesity by developing microRNA-based treatments that target …See details»
AptamiR Therapeutics - Overview, News & Similar companies
AptamiR is also developing drug delivery approaches that can specifically target microRNA modulators to adipose tissue. Read More. View Company Info for Free. Who is AptamiR …See details»
Philippe Camus - AptamiR
Mr. Camus is Chairman of the Board of Directors at AptamiR. He also holds the positions of Chairman of the Board at Alcatel-Lucent and Senior Advisor at Evercore Partners. Formerly, …See details»
OOO "APTAMIR": owners, founders, management, details (TIN
Aug 18, 2023 The organization OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "APTAMIR" was registered in the Unified State Register of Legal Entities 12 years ago 18 …See details»
Aptamer Group
Who is Aptamer Group? Aptamer Group is a leading provider of custom Optimer ® selection and development services. Optimer binders are next-generation aptamers delivering high affinity, …See details»
Investment Opportunity - AptamiR
Jun 1, 2021 AptamiR is now seeking to raise the first tranche ($5M) of Series B financing ($15-20M): To complete within 2 years the pre-IND and IND phases (Efficacy, Safety and …See details»
NeoVentures Biotechnology | Identifying & Developing Aptamers
NeoVentures does not sell a pre-set aptamer development package. We build collaborations with our clients that enable us to work together dynamically to overcome hurdles to the creation of …See details»
Targeted Delivery of microRNAs OligoNucleotide Therapeutics to …
Structure: AptamiR is a US modular Biotechnology Company currently executing the pre-clinical development of its OligoNucleotide Therapeutics (ONTs) drug candidates. Mission: Develop …See details»
Oligonucleotide Therapeutics with a Peptide Nucleic Acid
Sep 20, 2021 Mean Body Weight at week 8 of study Normal diet High-fat diet (60%) + anti-miR Rx for 8 week s 32.08 gm. 35.51 gm. High-fat diet (60%) 45.85gm. Results Body Weight …See details»